Converus AI, Inc. — SEC Form D Filing

Converus AI, Inc. filed an SEC Form D on September 25, 2026, reporting $20K raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
September 25, 2026
Amount reported
$20K
Round stage
Seed
Industry
Healthcare Technology
Website
https://www.converus.ai/

What the company does

Securities: Simple Agreement for Future Equity (SAFE). Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare organizations struggle with scattered, constantly changing reimbursement rules from various sources like policy PDFs, contracts, and portals, leading to billing based on outdated information and resulting in denials, rework, and missed reimbursement.

Solution

Converus provides a centralized, auto-updating system that translates payer policies, mandates, and contracts into structured, current billing rules for coverage, prior authorization, documentation, coding, rates, and appeals, which can be connected to existing billing systems and tools via API.

Why now

Payer rules, coverage criteria, and documentation requirements are constantly changing, making it impossible for healthcare providers to manually track. Denials cause significant financial loss, and existing contract terms are often unusable.

Verdict

Investors funded a clear pain point and a credible technical solution. This cleared because it offered a tangible financial benefit tied to revenue cycle efficiency, not because it promised a transformative shift in healthcare delivery. The implicit bet was on rapid integration into existing, complex healthcare IT stacks, requiring minimal behavioral change from entrenched operators. However, the reliance on API-based integration limited immediate revenue capture to established systems, constraining upside to the speed and depth of these integrations rather than new market creation.

Source: SEC EDGAR Form D filing